Stock Research for APRI

APRI

Featured Broker: Ally Invest

Get the due diligence for another stock.

 

APRI Stock Chart & Research Data

The APRI chart settings shown below allow you to select time intervals of 1 min, 30 mins, an hour or by day - week - month. There is also the ability to change the APRI chart style to candles, hollow candles, bars, lines or add various indicators. You can even add a symbol and compare history.


 


APRI Due diligence Resources & Stock Charts

The APRI stock resources shown below were gathered to cut back on time by allowing you to visit multiple sites at once. For your convenience each link clicked will open in a window. In addition to the individual links there is a button at the bottom that will allow you to open all the links at the same time. Note opening all links at once may not work with all browsers. Some browsers block multiple windows, to resolve this please allow that site to use pop-ups.

The Four Most Popular Resources

CNN View APRI Detailed Price Forecast - CNN Money CNN View APRI Detailed Summary - Google Finance
Yahoo View APRI Detailed Summary - Yahoo! Finance Zacks View APRI Stock Research & Analysis - Zacks.com

Stock Analysis

TradeIdeas View APRI Trends & Analysis - Trade-Ideas Barrons View APRI Major Holders - Barrons
NASDAQ View APRI Call Transcripts - NASDAQ Seeking View APRI Breaking News & Analysis - Seeking Alpha
Spotlight View APRI Annual Report - CompanySpotlight.com OTC Report View APRI OTC Short Report - OTCShortReport.com
TradeKing View APRI Fundamentals - TradeKing Charts View APRI SEC Filings - Bar Chart
WSJ View Historical Prices for APRI - The WSJ Morningstar View Performance/Total Return for APRI - Morningstar
MarketWatch View the Analyst Estimates for APRI - MarketWatch CNBC View the Earnings History for APRI - CNBC
StockMarketWatch View the APRI Earnings - StockMarketWatch MacroAxis View APRI Buy or Sell Recommendations - MacroAxis
Bullish View the APRI Bullish Patterns - American Bulls Short Pains View APRI Short Pain Metrics - ShortPainBot.com

Social Media Mentions

StockTwits View APRI Stock Mentions - StockTwits PennyStocks View APRI Stock Mentions - PennyStockTweets
Twitter View APRI Stock Mentions - Twitter Invest Hub View APRI Investment Forum News - Investor Hub
Yahoo View APRI Stock Mentions - Yahoo! Message Board Seeking Alpha View APRI Stock Mentions - Seeking Alpha


Financial & Transaction Holdings

SECform4 View Insider Transactions for APRI - SECform4.com Insider Cow View Insider Transactions for APRI - Insider Cow
CNBC View APRI Major Holdings Summary - CNBC OTC Markets View Insider Disclosure for APRI - OTC Markets
Yahoo View Insider Transactions for APRI - Yahoo! Finance NASDAQ View Institutional Holdings for APRI - NASDAQ


Stock Charts

FinViz View APRI Stock Insight & Charts - FinViz.com StockCharts View APRI Investment Charts - StockCharts.com
BarChart View APRI Stock Overview & Charts - BarChart Trading View View APRI User Generated Charts - Trading View




Latest Financial News for APRI


Apricus: 2Q Earnings Snapshot
Posted on Thursday August 09, 2018

On a per-share basis, the San Diego-based company said it had a loss of 10 cents. In the final minutes of trading on Thursday, the company's shares hit 27 cents. A year ago, they were trading at $1.33. ...


Apricus Biosciences Provides Corporate Update and Second Quarter 2018 Financial Results
Posted on Thursday August 09, 2018

Company Enters Into Merger Agreement with Seelos Therapeutics, Inc. SAN DIEGO, Aug. 09, 2018 (GLOBE NEWSWIRE) -- Apricus Biosciences, Inc. (APRI), a biopharmaceutical company historically focused on seeking to advance innovative medicines in urology and rheumatology, today reported financial results for the second quarter and first half of 2018 and provided a corporate update on its near-term priorities. On July 30, 2018, the Company announced the signing of a definitive agreement to merge with Seelos Therapeutics, Inc., a privately-held biotechnology company, in an all-stock transaction.


Apricus Biosciences, Inc. Announces Merger Agreement with Seelos Therapeutics, Inc. to Advance Late-Stage Pipeline of Products for Central Nervous System (CNS) Disorders
Posted on Monday July 30, 2018

Apricus Biosciences, Inc. (APRI) announced the signing of a definitive agreement to merge with Seelos Therapeutics, Inc., a privately-held biotechnology company, in an all-stock transaction. The merged company will focus on the development and commercialization of central nervous system (CNS) therapeutics with known mechanisms of action in areas with a highly unmet medical need.


Breakfast Technical Briefing on Amarin and Three Other Additional Biotech Stocks
Posted on Monday July 02, 2018

On Friday, June 29, 2018, US markets saw broad based gains with six out of nine sectors finishing the trading sessions in green. All you have to do is sign up today for this free limited time offer by clicking the link below.


Stock Market & Investing Books

Enter a stock symbol to view the stock details.